By Robb M. Stewart
Cosciens Biopharma appointed Anna Biehn as the specialty biopharmaceutical company's next chief executive, turning to an executive with more than 25 years experience in the consumer products and biosciences industries.
Biehn will take up the post May 5, succeeding Gilles Gagnon, who will remain with the Canadian company as a strategic adviser and director, Cosciens said Monday.
Biehn most recently served as the chief financial officer of NuTek Natural Ingredients, a "clean-label" and plant-based food ingredient company. Prior to her position s CFO, Biehn was vice president of strategy and marketing. She began her career at packaged food company Conagra, where she held a number of roles including as president responsible for leading the company's international business.
Gagnon last September said Cosciens' board had hired an executive recruiting firm to help identify the company's next president and CEO.
Cosciens, which was created with last year's all-stock merger of Aeterna Zentaris and Ceapro, develops and commercializes a portfolio of what it describes as cosmeceutical, nutraceutical and pharmaceutical products.
Write to Robb M. Stewart at robb.stewart@wsj.com
(END) Dow Jones Newswires
April 14, 2025 07:26 ET (11:26 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。